<b>Conclusions:</b> The SUVmax-IPI composite score, integrating PSMA PET/CT-derived metabolic tumor activity with systemic inflammatory burden, is independently associated with overall survival in metastatic prostate cancer. This evidence concerns the gene FOLH1 and neoplasm.